613
Participants
Start Date
December 31, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
Formoterol Turbuhaler® 4.5mg
4.5 mg inhaled twice daily
Formoterol Turbuhaler® 9 mg
9 mg inhaled twice daily
Turbuhaler® placebo
placebo inhaled twice daily
Research Site, Gabrovo
Research Site, Lovech
Research Site, Pleven
Research Site, Rousse
Research Site, Sofia
Research Site, Stara Zagora
Research Site, Troyan Municipality
Research Site, Varna
Research Site, Nagoya
Research Site, Seto
Research Site, Noda
Research Site, Touon
Research Site, Yanagawa
Research Site, Ōta
Research Site, Ōwa
Research Site, Hiroshima
Research Site, Asahikawa
Research Site, Chitose
Research Site, Obihiro
Research Site, Sapporo
Research Site, Tomakomai
Research Site, Yabu
Research Site, Naka-gun
Research Site, Morioka
Research Site, Kagoshima
Research Site, Kawasaki
Research Site, Kochi
Research Site, Kyoto
Research Site, Sendai
Research Site, Katano
Research Site, Kishiwada
Research Site, Osaka
Research Site, Takatsuiki
Research Site, Chiyoda City
Research Site, Wakayama
Research Site, Ube
Research Site, Deva
Research Site, Bucharest
Research Site, Constanța
Research Site, Iași
Research Site, Kazan'
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Dnipropetrovsk
Research Site, Donetsk
Research Site, Kharkiv
Research Site, Kyiv
Lead Sponsor
AstraZeneca
INDUSTRY